StemCells Inc. (NASDAQ:STEM) had its price target raised by S&P Equity Research from $1.07 to $1.20 in a report released on Thursday. S&P Equity Research’s price objective would indicate a potential upside of 14.29% from the stock’s current price.
Shares of StemCells (NASDAQ:STEM) opened at 1.05 on Thursday. The stock has a 50 day moving average price of $1.42 and a 200 day moving average price of $1.62. The firm’s market cap is $12.61 million. StemCells has a 52 week low of $0.33 and a 52 week high of $7.56.
StemCells Company Profile